Metropolitan Life Insurance Company (MetLife)’s Sensata Technologies ST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,102
Closed -$191K 2646
2021
Q4
$191K Buy
3,102
+9
+0.3% +$524 ﹤0.01% 2058
2021
Q3
$169K Buy
+3,093
New +$178K ﹤0.01% 2198
2021
Q2
Sell
-3,125
Closed -$181K 2863
2021
Q1
$181K Buy
3,125
+121
+4% +$6.98K ﹤0.01% 2087
2020
Q4
$158K Sell
3,004
-94
-3% -$4.52K ﹤0.01% 2095
2020
Q3
$134K Sell
3,098
-44
-1% -$1.79K ﹤0.01% 2048
2020
Q2
$117K Sell
3,142
-3,664
-54% -$129K ﹤0.01% 2155
2020
Q1
$197K Sell
6,806
-145
-2% -$6.26K ﹤0.01% 1596
2019
Q4
$374K Sell
6,951
-204
-3% -$10.5K 0.01% 1513
2019
Q3
$358K Sell
7,155
-1,135
-14% -$53.7K 0.01% 1502
2019
Q2
$406K Sell
8,290
-150
-2% -$7.14K 0.01% 1438
2019
Q1
$380K Buy
+8,440
New +$400K 0.01% 1471

Other funds holding ST

Metropolitan Life Insurance Company (MetLife)'s ST Position: Q1 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Sensata Technologies (ST) in Q1 2022, closing a stake of 3,102 shares — an estimated $191K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ST in Q1 2019 and held it in 11 quarters. The position peaked at $406K in Q2 2019. 377 funds tracked by Wall St. Rank hold ST as of Q1 2022.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Sensata Technologies position as of Q1 2022 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 3,102 Sensata Technologies shares in Q1 2022, an estimated $191K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Sensata Technologies in Q1 2019 and held it in 11 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Sensata Technologies position peaked at $406K in Q2 2019.
  • 377 funds tracked by Wall St. Rank held Sensata Technologies as of Q1 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.